Loading…

ECT beyond unipolar major depression: systematic review and meta‐analysis of electroconvulsive therapy in bipolar depression

Objective In this systematic review and meta‐analysis, the response, remission, and speed of response in adults with major depressive disorder (MDD) and bipolar disorder in depressive episode (BDD) receiving an acute course of electroconvulsive therapy (ECT) were quantitatively analyzed. Methods Usi...

Full description

Saved in:
Bibliographic Details
Published in:Acta psychiatrica Scandinavica 2019-03, Vol.139 (3), p.214-226
Main Authors: Bahji, A., Hawken, E. R., Sepehry, A. A., Cabrera, C. A., Vazquez, G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective In this systematic review and meta‐analysis, the response, remission, and speed of response in adults with major depressive disorder (MDD) and bipolar disorder in depressive episode (BDD) receiving an acute course of electroconvulsive therapy (ECT) were quantitatively analyzed. Methods Using the Preferred Reporting Items for Systematic Reviews and Meta‐analysis guidelines, 1660 citations were identified through five electronic databases. Nineteen articles met final inclusion criteria for meta‐analysis. Results The pooled response and remission rates with ECT in MDD were 74.2% (n = 1246/1680) and 52.3% (n = 850/1626), respectively. In BDD, they were 77.1% (n = 437/567) and 52.3% (n = 275/377), respectively. Although response rates to ECT were statistically higher in BDD (OR = 0.73, 95% CI: 0.56–0.95, P = 0.02), remission rates were similar (OR = 0.91, 95% CI: 0.65–1.26, P = 0.56). Individuals with BDD vs. MDD required fewer number of ECT sessions to achieve response (SMD = −0.23, 95% CI: −0.44 to −0.023, P = 0.03). There were no significant moderator effects identified. Conclusion Response rates and speed of response are higher in individuals with BDD; however, remission rates are equivalent. These findings support increased utilization of ECT in individuals with treatment‐refractory BDD.
ISSN:0001-690X
1600-0447
DOI:10.1111/acps.12994